Effect of NKG2D in eliminating hematological malignant cell lines by natural killer cells.
- Author:
Wei WANG
1
;
Li GAO
;
Yi-Gai MA
Author Information
1. Department of Hematology, Beijing China-Japan Friendship Hospital, Beijing, China. wwpku2000@hotmail.com
- Publication Type:Journal Article
- MeSH:
Cell Line, Tumor;
Flow Cytometry;
Hematologic Neoplasms;
immunology;
metabolism;
Humans;
Killer Cells, Natural;
immunology;
NK Cell Lectin-Like Receptor Subfamily K;
immunology;
metabolism
- From:
Journal of Experimental Hematology
2012;20(2):296-299
- CountryChina
- Language:Chinese
-
Abstract:
The aim of this study was to clarify whether NKG2D plays an activating role in eliminating hematological malignant cells lines by natural killer (NK) cells. Several hematological malignant cell lines (K562, NB4, Kasumi-1 THP-1, MV-4-11, MOLT-4, Jurkat, RS4; 11, Raji) were used as target cells. The expression levels of major histocompatibility complex class I (MHC I)-related molecules A/B (MICA, MICB), whose corresponding ligand was NKG2D, were detected in target cells by flow cytometry. Firstly, the target cell lines were co-incubated with carboxyfluorescein succinimidyl ester (CFSE) for 30 min. In the meanwhile, NK92MI, a kind of NK cell line, was co-incubated respectively with isotype control antibody or blocking antibody, the latter could block NKG2D specifically. Then, NK92MI cells were co-cultured with different target cell lines. After incubation for 2 h, the apoptotic ratio of each target cell line was detected by flow cytometry. The results demonstrated that there was a significant reduction of the apoptotic ratio in Kasumi-1, an acute myeloid leukemia cell line, when NK92MI cells were incubated with NKG2D blocking antibody previously. In contrast, the apoptotic ratio of other cell lines varied minimally. It is concluded that NKG2D can activate NK cells through inducing cytotoxicity to certain target cells.
